Montpellier-based Deinove has named a new Chief Executive Officer. Alexis Rideau took over the helm of the company in the beginning of May.

University of Goergia researchers have decribed the shielded versions of the viral S-protein. a. Side view (upper panels) and Top view (lower panels) of the SARS-CoV-2 S protein (grey surface) with homogeneous Complex glycosylation (magenta) showing aligned antibody fragments (ribbons) from co-complexes with the S glycoproteins from SARS-CoV-1 (orange) and MERS (cyan) 48,50-61 . b. Glycans present on SARS-CoV-2 S glycoprotein that are incompatible with known antibody positions due to steric overlap are shown in yellow. a. Side view (upper panels) of the SARS-CoV-2 S protein (grey) with homogeneous complex glycosylation (magenta) showing aligned antibody fragments (ribbons) from co-complexes with the S glycoproteins from SARS-CoV-1 (orange) and MERS (cyan). b. Glycans present on SARS-CoV-2 S glycoprotein that are incompatible with known antibody positions due to steric overlap are shown in yellow. c. Potential antibody poses after elimination of epitopes blocked by S protein glycosylation. © Doi: 10.1101/2020.04.07.030445

British researchers have deciphered the glycosylation pattern of the viral spike protein of SARS-CoV-2 laying the foundation for vaccine development.

© ElisaRiva/pixabay.com

Newron Pharmaceuticals S.p.A.‘s Sarizotan failed to meet efficacy endpoints in the Phase III STARS study.

German Health Minister Jens Spahn at Roche's Penzberg site. © Roche

Roche Diagnostics has received FDA Emergency use approval for its highly specific Elecsys antibody test.

96-well EchoLUTION RNA/DNA extraction - flowchart. Just one centrifugation step is required to obtain highly pure inhibitor-free nucleic acid. If throat swabs are stored in a denaturating buffer, the processing time for 96 samples is reduced to only 5 minutes. Bioecho recently received the award „innovative through research. Picture: BioEcho

BioEcho develops single-spin and 96/384-well kits based on the proprietary single-step EchoLUTION nucleic acid extraction process. Highly superior to the commonly used Silica-based solutions (bind-wash-elute), the whole procedure is extremely fast. Washing steps are not required and the isolated inhibitor-free RNA/DNA is detected with increased sensitivity. Due to the expertise of its founders and employees, BioEcho also uses their know-how to support companies with limited research capacities or specialized scientific knowledge. Especially in times like these, BioEcho helps to accelerate accurate tests on certain RNA/DNA viruses or pathogens.

Euro_Guide_App_2020.jpeg

Additional to the print edition the European Biotechnology Science & Industry Guide 2020 is available digital in the App Store and at Google Play. Download the free BIOCOM app on smartphone, tablet or laptop and have the complete edition in one hand.

Austrian Phagomed wants to close a Series A financing in 2020. The start-up is working on phage-based treatments as a new alternative to antibiotics.

London-based Syncona Ltd announces the appointment of Danny Bar-Zohar as Syncona Partner, starting mid of April.

© Bone Therapeutics SA

Belgian Bone Therapeutics SA has secured €11m to foster development of its late stage pipeline candidates.

© Cevec Pharmaceuticals GmbH

Cevec Pharmaceuticals GmbH has launched a new, scalable production platform for AAV gene therapy vectors.